Proteomics of human breast ductal carcinoma in situ. - Wikidata - awgldk - TriplyDB

Proteomics of human breast ductal carcinoma in situ.

Proteomics of human breast ductal carcinoma in situ.

http://www.wikidata.org/entity/Q30870715

about

Genetic alteration and gene expression modulation during cancer progression The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast Putative biomarkers and targets of estrogen receptor negative human breast cancer Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma Proteomics and mass spectrometry for cancer biomarker discovery Quantitative proteomics employing primary amine affinity tags Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma Gene profiling of cottontail rabbit papillomavirus-induced carcinomas identifies upregulated genes directly Involved in stroma invasion as shown by small interfering RNA-mediated gene silencing Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells.Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry.Do serum biomarkers really measure breast cancer?A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast Is the small heat shock protein alphaB-crystallin an oncogene?Laser capture microdissection for protein and NanoString RNA analysis 14-3-3ζ as a prognostic marker and therapeutic target for cancer Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.The changing role of pathology in breast cancer diagnosis and treatment.c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.Classification of ductal carcinoma in situ by gene expression profiling.Screening for therapeutic targets of vorinostat by SILAC-based proteomic analysis in human breast cancer cells.Ductal carcinoma in situ: recent advances and future prospects.Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer.Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer.Application of proteomics in the study of tumor metastasis.Breast tumor metastasis: analysis via proteomic profiling.Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer Progression Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.

P2860

Q24798750-02C6836A-B0F8-4DEE-A081-3792FE3C946E Q24803014-6ACB361E-CCD2-4D19-9FB6-669A8AE90690 Q24805971-2787B61B-E78A-473C-83D1-E7A8C0796A4D Q27003285-E71A45B3-55D8-4E6F-A090-EE3014BA50C1 Q27025430-62EC77CC-EBA0-42E1-89EE-89FD05C9E800 Q28285857-B10E9B68-83FD-4586-BF15-22DB32BDBB4D Q28766969-1A49DEC1-B0B0-472F-914E-1EF0AB7A82A1 Q30988065-D3593724-5A37-4FA2-9C98-AE4AD2DEB8CD Q30990299-05E2928C-FCD7-40A9-A97A-4E27EE96FEEA Q33204255-514B87DC-D375-44DD-9527-4C3DD3965B25 Q33224181-227B0695-DAFE-46E7-9156-1EA065CDD673 Q33236750-59228783-CA70-41EB-AB24-2171B724ACB0 Q33241448-3A014F1C-D56F-4F34-9565-8BFD805A38E8 Q33327496-3BDC99CA-6D30-42F0-A5AA-345BB2936BBF Q33454967-932B84FF-5069-4C77-BD40-1EAE1D999B71 Q33568539-DA8BF094-F366-4E57-B47E-DB35B04A46C2 Q33591231-1CBA8B5E-A428-46E6-B784-FEE2330E33B3 Q33625197-CA018D2B-86CB-4294-8AAD-5F0C6AAB5077 Q33672680-AFDB551C-9191-4E82-A752-AC6E4FAE66F9 Q33992717-8B1075A1-CE15-4C0C-A856-A4E18B12A95D Q34207931-8460B803-B148-4789-9B7E-3926B518A450 Q34245398-B5387157-A19B-4209-BF1E-1E5CD8D9433A Q34425869-E2DD0BD7-A0F1-4799-BB18-987A6D6D71B1 Q34473399-6A282FE4-3E4E-462E-87D1-5D50E716ACAA Q34737626-6D44A9F9-0A5D-4FBC-B758-6C570393C67F Q34972287-57D74507-A2EE-4BB4-8DFE-FC79A818877E Q35082260-056B24F2-EDE2-47EE-8515-77E3C8452591 Q35084895-310207F7-1A9D-4121-B569-DD9B41ACE41A Q35165997-C760A633-338F-4B87-AD09-8B0E71E60C6C Q35589437-C2D2319E-7F82-4955-89F3-F1E74B0107CF Q35605885-8964233D-8F12-4E04-9AD9-F15FC96AA734 Q35914300-1C98FA6E-42E9-487D-B685-87747DC39D59 Q35996817-DBA1F345-2B2E-40C7-B056-296B9FAFBDF5 Q36105177-15624E01-BB37-4E40-ACF9-D0A5A3497473 Q36109380-751C5BAB-927F-4D2A-80C8-E3BE8BCD302B Q36111028-A3B45070-168E-4A77-9594-A88E85A918AF Q36146166-5217A4AE-632D-455F-9633-2DAE6290BB05 Q36394968-4056DD01-614E-4732-86C4-0D54FD36DF55 Q37141148-59542D52-3AAB-43C9-8D90-3776ADD7A3BF Q37212428-0249BA05-27C9-4F30-BE6C-657D171865A1

P2860

Proteomics of human breast ductal carcinoma in situ.

http://www.wikidata.org/entity/Q30870715

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Proteomics of human breast ductal carcinoma in situ.

@ast

Proteomics of human breast ductal carcinoma in situ.

@en

type

label

Proteomics of human breast ductal carcinoma in situ.

@ast

Proteomics of human breast ductal carcinoma in situ.

@en

prefLabel

Proteomics of human breast ductal carcinoma in situ.

@ast

Proteomics of human breast ductal carcinoma in situ.

@en

P1433

Q30870715-D721E3A8-F02D-4F14-AF73-A83E0416C11F

P1476

Q30870715-CEE1775E-B560-4AE7-B406-A51380583C04

P2093

Q30870715-15B56D21-2A00-4C23-ADB5-46CF86D8FDCA

Q30870715-3043F6BC-6131-4BE5-BB9E-3AF5C7495D37

Q30870715-3FEE7ACF-8EA6-421E-80AF-BF55B59E22B3

Q30870715-48813C8A-202B-4310-8F6A-31A23AFCEE95

Q30870715-5089E408-16A3-4742-ADF1-FEEF02D6777C

Q30870715-796E65F5-1B3B-49D1-9C26-D51FEEE54F4F

Q30870715-7EFF18A6-A314-4DCF-933F-180C8E30B440

Q30870715-87F4C81C-6C22-4AA1-AA44-4F60749DB5C6

Q30870715-88E21F2A-053F-4C5C-A252-B9F1AD0CA32B

Q30870715-8C57FC34-B1CD-4C4B-B8BE-1A04E35AAD0B

P304

Q30870715-0CD7F8E2-F6AA-4628-849E-798D98AB367F

P31

Q30870715-E1586758-3439-4AB9-9AA2-1737A6920F91

P407

Q30870715-8770778E-0016-4DE3-B656-47E3CF6E299D

P433

Q30870715-00E8F77C-8925-4114-A506-BAF98E21BC2A

P478

Q30870715-119223CD-9460-4C84-ACC5-CD5F2EB9EE00

P50

Q30870715-D284C50C-166E-497D-9316-AD0299DE4AAC

P577

Q30870715-918A9DFB-1DD7-4B9E-AABD-86EFFBB147CB

P698

Q30870715-EA1D8C60-715C-4541-8A42-F903EC8B54A7

P1433

Cancer Research

P1476

Proteomics of human breast ductal carcinoma in situ

@en

P2093

Aysegul Sahin

http://www.w3.org/2001/XMLSchema#string

Dennis C Sgroi

http://www.w3.org/2001/XMLSchema#string

Diethelm Wallwiener

http://www.w3.org/2001/XMLSchema#string

Emanuel F Petricoin

http://www.w3.org/2001/XMLSchema#string

Henry Krutzsch

http://www.w3.org/2001/XMLSchema#string

Hongjun Shu

http://www.w3.org/2001/XMLSchema#string

Julia D Wulfkuhle

http://www.w3.org/2001/XMLSchema#string

Kelley McLean

http://www.w3.org/2001/XMLSchema#string

Kelly McGarvey

http://www.w3.org/2001/XMLSchema#string

Maria J Merino

http://www.w3.org/2001/XMLSchema#string

P304

6740-6749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Diethelm Wallwiener

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12438275

http://www.w3.org/2001/XMLSchema#string